Wacker Biotech is a CDMO for the GMP-compliant production of active ingredients for the pharmaceutical industry
Combination will create a Canadian Health Champion spanning generic, biosimilar and branded pharmaceuticals
Lunaphore's flagship COMET technology is the only fully-automated, high-throughput, hyperplex platform with superior tissue profiling capabilities
The company had earlier announced about the approval received from the MHRA for Liraglutide
Liraglutide is a drug-device combination formulation used in the treatment of Type 2 Diabetes Mellitus
This partnership combines Tata Elxsi's design and technology expertise along with Dräger's expertise in medical and safety technology
The facility will manufacture tablets, capsules, and injections for the oncology segment
The report underscores significant advancements in healthcare delivery, showcasing how GenAI facilitates improved diagnostic accuracy, operational efficiency and patient engagement
Combination shows consistent benefit across prespecified post-progression outcomes
Ukrainian marketing approvals for paclitaxel, oxaliplatin and irinotecan mark a significant milestone in the company’s global expansion strategy
Subscribe To Our Newsletter & Stay Updated
